Last update:
Weight management news
New body index aims to move beyond BMI and works for babies too
Body Mass Index (BMI) has long been used in public health and clinical settings as a simple tool to classify an individual's physical status based on their height and weight. Originally developed in the 1830s by Belgian mathematician ...
6 hours ago
0
3
Medical spas and pharmacies offering compounded weight-loss drugs despite regulatory concerns
Despite the end of federal shortages of popular GLP-1 weight-loss medications, the market for compounded alternatives remains strong—and some patients may unknowingly be receiving products from pharmacies with concerning ...
5 hours ago
0
0
Impact of overweight on cancer risk may be significantly underestimated
Being overweight and obesity may contribute to significantly more cancer cases than previously thought. This is the conclusion reached by researchers at the German Cancer Research Center (DKFZ). Their analysis shows that ...
21 hours ago
0
4
How weight loss drugs pose challenges for plastic surgeons
The popularity of GLP-1 drugs has created a new generation of body contouring patients and a new set of challenges for plastic surgeons.
22 hours ago
0
4
Study identifies patients with obesity most likely to benefit from GLP-1-based treatment
Why do some people lose substantial weight with GLP-1-based medications while others see more modest results? A Mayo Clinic study offers a potential answer by identifying a distinct biological subtype of obesity that responds ...
Jul 16, 2026
0
3
Common diet tips about water intake and spicy foods could be wrong
The common rationale for drinking water at meals is that it physically stretches the stomach, triggering fullness so you don't eat too much. But a new Cornell study found no support for that idea in practice. The paper is ...
Jul 16, 2026
0
25
Rise of GLP-1s raises long-term affordability questions
As use of GLP-1s surged across the U.S., average total payments per user also climbed sharply, according to a new Northwestern University study that analyzed national trends in GLP-1 use and spending between 2017 and 2022. ...
Jul 16, 2026
0
4
What's driving the obesity pandemic?
New research presented at the International Congress on Obesity (ICO2026), hosted by the World Obesity Federation (WOF) in Mexico City, Mexico, (15–17 July) asks what is driving the obesity pandemic.
Jul 16, 2026
0
5
Ozempic-like drugs have more benefits to the body than just losing weight, meta-analysis shows
A meta-analysis of 10 randomized controlled trials involving more than 23,000 participants, presented at the International Congress on Obesity (ICO 2026), hosted by the World Obesity Federation (WOF) in Mexico City, Mexico ...
Jul 16, 2026
0
3
Weight loss drugs could help with binge eating disorder
Drugs commonly used for weight loss, known as GLP-1 receptor agonists, have been found to reduce the key symptoms of binge eating disorder in a new review of evidence led by University College London (UCL) researchers.
Jul 15, 2026
0
5
Internet searches on weight-loss medications have increased 25-fold since the launch of GLP-1 drugs
Public interest in obesity medication has risen 25-fold since the launch of GLP-1 receptor agonist drugs, new research presented at the International Congress on Obesity (ICO2026) in Mexico City, Mexico, hosted by the World ...
Jul 15, 2026
0
19
Coca-Cola 'sportswashing' during World Cup amplified by social media
New research being presented at the International Congress on Obesity (ICO2026), hosted by the World Obesity Federation (WOF) in Mexico City, Mexico (July 15–17), reveals how Coca-Cola's sponsorship of the 2025 FIFA Club ...
Jul 15, 2026
0
4
Changing behavior to aid weight loss may be linked to reduced risks of obesity related cancers
A new systematic review and meta-analysis presented at the International Congress on Obesity (ICO2026), hosted by the World Obesity Federation (WOF) in Mexico City, Mexico, July 15–17, is the first study to show that behavioral ...
Jul 15, 2026
0
3
Muscles matter for diabetes risk, new study finds
A major new international study led by Curtin University has found diabetes risk is about more than body weight or obesity, revealing that muscle health also likely plays a major role in whether people develop the condition.
Jul 14, 2026
0
10
Why food skills belong in the school curriculum—not left to chance at home
One in 10 children ages 7 to 9 is living with obesity in Europe. In England, childhood obesity rises from around 10% of children in Reception to around 22% by Year 6. While we know there are many complex and inter-connected ...
Jul 14, 2026
0
3
The GLP‑1 disclosure dilemma: Should you tell a date you're using Ozempic for weight loss?
As a Gen Xer who lived through the "heroin chic" years, when skeletal models were celebrated for jutting bones and sallow skin, the recent popularity of the #Y2KSkinny trend fills me with dread.
Jul 14, 2026
0
2
Study finds obesity 'fuels' leukemia, but a combo using popular weight-loss drugs may stop it
Obesity can act as fuel for leukemia, according to a study led by Indiana University School of Medicine scientists. To help patients facing aggressive blood cancers overcome this metabolic risk, researchers identified a potential ...
Jul 13, 2026
0
6
Study shows promising outcomes for bariatric surgery in adolescents and young adults with severe obesity
A new study from researchers at LSU's Pennington Biomedical Research Center, FMOL Health | Our Lady of the Lake Regional Medical Center and Metamor Institute demonstrates that metabolic and bariatric surgery can be delivered ...
Jul 13, 2026
0
2
Knowledge about genes isn't enough: How to inform people about genetic risk of obesity
Does informing people about their genetic risk of obesity help them change their habits and lose excess weight? A study published in the journal Obesity Reviews by scientists, including researchers from SWPS University, shows ...
Jul 13, 2026
0
1
Night owls eat later, choose less nutritious food, carry more belly fat and show higher metabolic risk
For generations, early to bed and early to rise was seen as the blueprint for a healthy life, and any departure from it was often considered unhealthy. Scientists, however, have discovered that whether someone is an early ...
Forget GLP-1s—GLP-3s show promise in phase 3 weight loss and diabetes trial
Phase 3 clinical trial results (TRANSCEND-T2D-1) published in The Lancet report that retatrutide, an investigational once-weekly injection for diabetes management, can significantly improve blood sugar levels and lead to ...
Jul 11, 2026
0
858
Weight‑loss jabs may create a new kind of yo‑yo dieting
For many people living with obesity, newer weight-loss medicines such as Wegovy and Mounjaro have been transformative. These drugs are often grouped under the label GLP-1 medicines because they mimic hormones released after ...
Jul 10, 2026
0
6
Researchers uncover hormone link between gut and brain in anorexia nervosa
People with anorexia nervosa have unusually high levels of a hormone called LEAP2 in their blood when they are in the acute phase of the disorder, according to research presented at the Federation of European Neuroscience ...
Jul 9, 2026
0
4
New treatment helps achieve a healthier BMI in people with weight dysregulation after brain tumors
A new therapy helps achieve a healthier BMI in people whose weight has become dysregulated following treatment for a brain tumor, a clinical trial has found. The results of the trial have been published in the New England ...
Jul 9, 2026
0
3
